Compare Stocks
Compare up to four stocks to (CYTK) by adding the symbol or company name.
CYTK
Compare up to three stocks to CYTK by adding the symbol or company name. | Add Stock | Add Stock | Add Stock |
As of May 09, 2024 | CYTK Cytokinetics, Incorporated | -- | -- | -- |
---|---|---|---|---|
Market Value | Market Value 6.69B | Market Value -- | Market Value -- | Market Value -- |
Enterprise Value | EV 6.97B | EV -- | EV -- | EV -- |
Price to Earnings | Price to Earnings -- | Price to Earnings -- | Price to Earnings -- | Price to Earnings -- |
Diluted Earnings Per Share | Diluted EPS TTM -5.45 | Diluted EPS TTM -- | Diluted EPS TTM -- | Diluted EPS TTM -- |
Forward Dividend & Yield | Fwd Div Yld -- | Fwd Div Yld -- | Fwd Div Yld -- | Fwd Div Yld -- |
Sector | Sector Healthcare | Sector -- | Sector -- | Sector -- |
Industry | Industry Biotechnology | Industry -- | Industry -- | Industry -- |
CEO | CEO -- | CEO -- | CEO -- | CEO -- |
As of May 09, 2024 | CYTK Cytokinetics, Incorporated | -- | -- | -- |
---|---|---|---|---|
1 Week | 1 Week 1.03% | 1 Week -- | 1 Week -- | 1 Week -- |
3 Months | 3 Months -18.90% | 3 Months -- | 3 Months -- | 3 Months -- |
YTD | YTD -23.32% | YTD -- | YTD -- | YTD -- |
1 Year | 1 Year 66.68% | 1 Year -- | 1 Year -- | 1 Year -- |
As of May 09, 2024 | CYTK Cytokinetics, Incorporated | -- | -- | -- |
---|---|---|---|---|
Revenue | Revenue 7.53M | Revenue -- | Revenue -- | Revenue -- |
Operating Expenses | Operating Expenses 173.61M | Operating Expenses -- | Operating Expenses -- | Operating Expenses -- |
Operating Income | Operating Income -496.20M | Operating Income -- | Operating Income -- | Operating Income -- |
Revenue Growth YoY | Rev Gr 1Y -14.56% | Rev Gr 1Y -- | Rev Gr 1Y -- | Rev Gr 1Y -- |
Gross Profit | Gross Profit -322.59M | Gross Profit -- | Gross Profit -- | Gross Profit -- |
As of May 09, 2024 | CYTK Cytokinetics, Incorporated | -- | -- | -- |
---|---|---|---|---|
Inventory | Inventory -- | Inventory -- | Inventory -- | Inventory -- |
Account Receivables Turnover | A/R Turnover 10.53 | A/R Turnover -- | A/R Turnover -- | A/R Turnover -- |
As of May 09, 2024 | CYTK Cytokinetics, Incorporated | -- | -- | -- |
---|---|---|---|---|
Cash Flow from Operations | CF from Ops -414.33M | CF from Ops -- | CF from Ops -- | CF from Ops -- |
Capital Expenditures | CapEx -1.42M | CapEx -- | CapEx -- | CapEx -- |
Cash from Investing Activities | CFI 239.25M | CFI -- | CFI -- | CFI -- |
Free Cash Flow | Free Cash Flow -415.75M | Free Cash Flow -- | Free Cash Flow -- | Free Cash Flow -- |
As of May 09, 2024 | CYTK Cytokinetics, Incorporated | -- | -- | -- |
---|---|---|---|---|
Price to Earnings Per Share | P/E -- | P/E -- | P/E -- | P/E -- |
Forward Price to Earnings Per Share | Fwd P/E -- | Fwd P/E -- | Fwd P/E -- | Fwd P/E -- |
Price to Free Cash Flow Per Share | P/FCF -- | P/FCF -- | P/FCF -- | P/FCF -- |
Price to Book Value Per Share | P/BV -- | P/BV -- | P/BV -- | P/BV -- |
Price to Sales Ratio | P/S 836.67 | P/S -- | P/S -- | P/S -- |
EV/EBITDA | EV/EBITDA -15.25 | EV/EBITDA -- | EV/EBITDA -- | EV/EBITDA -- |
As of May 09, 2024 | CYTK Cytokinetics, Incorporated | -- | -- | -- |
---|---|---|---|---|
Operating Margin | Oper. Margin -6,589.71% | Oper. Margin -- | Oper. Margin -- | Oper. Margin -- |
Gross Margin | Gross Margin -4,284.10% | Gross Margin -- | Gross Margin -- | Gross Margin -- |
Profit Margin | Profit Margin -6,988.63% | Profit Margin -- | Profit Margin -- | Profit Margin -- |
As of May 09, 2024 | CYTK Cytokinetics, Incorporated | -- | -- | -- |
---|---|---|---|---|
Basic Earnings Per Share | EPS -5.45 | EPS -- | EPS -- | EPS -- |
EPS 1Yr Growth | EPS 1Yr Growth 0.00% | EPS 1Yr Growth -- | EPS 1Yr Growth -- | EPS 1Yr Growth -- |
As of May 09, 2024 | CYTK Cytokinetics, Incorporated | -- | -- | -- |
---|---|---|---|---|
Return on Assets | Return on Assets -57.23% | Return on Assets -- | Return on Assets -- | Return on Assets -- |
Return on Capital | Return on Capital -60.45% | Return on Capital -- | Return on Capital -- | Return on Capital -- |
As of May 09, 2024 | CYTK Cytokinetics, Incorporated | -- | -- | -- |
---|---|---|---|---|
Institutional Ownership % | Inst. Own. % 112.77% | Inst. Own. % -- | Inst. Own. % -- | Inst. Own. % -- |